WHWK logo

Whitehawk Therapeutics, Inc. Stock Price

NasdaqCM:WHWK Community·US$168.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

WHWK Share Price Performance

US$3.16
1.38 (77.53%)
US$3.16
1.38 (77.53%)
Price US$3.16

WHWK Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

Whitehawk Therapeutics, Inc. Key Details

US$7.1m

Revenue

US$91.7m

Cost of Revenue

-US$84.6m

Gross Profit

-US$64.0m

Other Expenses

-US$20.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.44
-1,183.74%
-288.26%
0%
View Full Analysis

About WHWK

Founded
2007
Employees
23
CEO
David Lennon
WebsiteView website
ir.whitehawktx.com

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Recent WHWK News & Updates

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth

Jan 17
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth

Recent updates

No updates